FDA Clears Genetic Test for Cancer Risk Assessment
FDA grants first-of-its-kind approval for Invitae's Hereditary Cancers Panel, reforming cancer risk detection.
Stay updated with breaking news from Genetic Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA grants first-of-its-kind approval for Invitae's Hereditary Cancers Panel, reforming cancer risk detection.
Earlier diagnostic screening, routine and emerging therapies, and increased awareness are helping people with the lysosomal storage disorder Fabry disease lead a longer, healthier life.
A recent study published in the Journal of the American Medical Association found that "whole genome" tests are twice as effective as narrower tests in identifying genetic abnormalities that can cause disease in infants.
The Stem Cell Therapy market research report works as a backbone for the growth of the healthcare industry. Hence the report has been provided with comprehensive market insights and analysis that offer an advanced perspective of the marketplace. The report provides CAGR values along with its fluctuations for the spe...
Within the brain itself, young-onset Alzheimer's disease causes similar chemical changes as those in late-onset Alzheimer's. But the brain areas targeted by these chemical changes can be different.